New guidance for cancer pain and opioid use disorder or opioid misuse
Opioids are a cornerstone of cancer pain management, but there is a lack of consensus on how to treat pain in cancer patients who also have struggled with… read more.
Opioids are a cornerstone of cancer pain management, but there is a lack of consensus on how to treat pain in cancer patients who also have struggled with… read more.
PD-1 blockade with adjuvant dostarlimab in mismatch repair–deficient, locally advanced rectal cancer shows signs of high efficacy, researchers reported on June 5, 2022 in the NEJM/ New England… read more.
Pain management is one of the biggest challenges of the modern healthcare system. Almost 60% of US adults report having experienced pain in the past three months and… read more.
A new study by a University of South Florida researcher found important revelations that could provide chain-operated nursing homes with crucial implications for operational goals and strategic findings… read more.
Pediatric obesity remains a serious health problem in the United States, where one in five children are affected. The U.S. Preventive Services Task Force now recommends that pediatricians… read more.
A sensor-equipped computer program can accurately identify and count arm movements in people undergoing stroke rehabilitation, a new study shows. Now that it can do so, the next… read more.
For children and young people, skin disorders can have a devastating impact on physical and mental wellbeing, yet effective treatments are few and far between. That’s why the… read more.
China’s medical products regulator has given conditional approval for Pfizer’s COVID-19 drug Paxlovid, making it the first oral pill specifically developed to treat the disease cleared in the… read more.
Global Blood Therapeutics announced the European Commission (EC) has granted Marketing Authorization for Oxbryta (voxelotor) for the treatment of hemolytic anemia due to sickle cell disease (SCD) in… read more.
Older adults with untreated sight conditions may be at increased risk of dementia, according to a new systematic review and meta-analysis of 16 studies involving 76,373 participants. The… read more.
Heron Therapeutics, Inc., announced that Health Canada has issued a Notice of Compliance (NOC) to commercialize Zynrelef (bupivacaine and meloxicam extended-release solution) for instillation into the surgical wound… read more.
Percutaneous nephrolithotomy (PCNL) is an efficient, minimally-invasive, gold standard procedure used for removing large kidney stones. Creating an access from the skin on the back to the kidney… read more.